Journal of Bioequivalence & Bioavailability

IP strategies for the biosimilar arena

International Conference and Exhibition on Biowaivers & Biosimilars

September 10-12, 2012 Hilton San Antonio Airport, USA

Ulrich Storz

Accepted Abstracts: J Bioequiv Availab

Abstract:

The patent term of some of the most important biopharmaceutic blockbusters is about to expire in the near future. While originators strive to extend the effective protection term for their major assets, biosimilar manufacturers prepare for market entry of their follow-on products. The situation of biosimilars is in part comparable with that of small molecule generics, although significant differences apply, caused, among others, by post-translational dfferences biosimilars have compared to the respective archetype drug This oral presentation will discuss active and passive IP strategies for both originators and biosimilar manufacturers

Biography :

Ulrich Storz was born in 1969 in Muenster. He graduated in Biology at the University of Muenster in 1998, where he received his PhD in 2002. He is author and co-author of several scientific publications in the field of biology and biophysics as well as of several publications in the field of intellectual property. He passed the German Patent Bar Examination in 2005. Since 2005, he has been admitted to practice as European Trademark Attorney at the European Trademark Office (OHIM). In 2006, he has been registered in the list of representatives before the European Patent Office. Main practice areas in the field of Intellectual Property Law include Patent Prosecution, FTO and Patent Infringement, as well as Patent strategies; especially in the Life Science field (i.e. Biotechnology, Biophysics, Biochemistry and Microbiology). One of his preferred fields of expertise are therapeutical antibodies. Ulrich Storz is active as a speaker for the congress management company ?Forum Institut f?r Management GmbH?. He organizes the ?Rhineland Biopatent Forum?, which takes place annually in May or June, and he is the editor of the textbook series ?SpringerBriefs in Biotech Patents.? Further, Ulrich has a lectureship at the University of Applied Sciences in Gelsenkrichen, Germany